Loading provider…
- Featuresarrow_drop_down
- Solutionsarrow_drop_down
Loading provider…
Your Medical Sales Assistants that help you easily find, convert and close your ideal providersNeurology Physician in San Francisco, CA
NPI: 1437186855Primary Practice Location
UCSF MEDICAL CENTER
1975 4th St, San Francisco, CA
Primary Employer
UCSF Medical Center
ucsfhealth.org
HQ Phone
Get M.D. Chadwick's Phone NumberMobile
Get M.D. Chadwick's MobileLooking to connect with more Physicians?
Dmand AI gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Get Started for Freearrow_outwardCA State Medical License
CA State Medical License
1993 - 2027
American Board of Psychiatry and Neurology
Neurology
Weill Cornell Medicine
weill.cornell.edu
Medical School
Until 1991
UCSF School of Medicine
medschool.ucsf.edu
Internship • Internal Medicine
1991 - 1992
Residency • Neurology
1992 - 1995
| # | Procedure Code (CPT®/HCPCS II) | Procedure Patients | Procedure Volume |
|---|---|---|---|
| 1 | 99214Established patient office or other outpatient visit, 30-39 minutes | 155 | 214 |
| 2 | 99215Established patient office or other outpatient, visit typically 40 minutes | 111 | 148 |
| 3 | 99213Established patient office or other outpatient visit, typically 15 minutes | 92 | 120 |
| 4 | 99205New patient office or other outpatient visit, typically 60 minutes | 22 | 22 |
| 5 | 99204New patient office or other outpatient visit, 45-59 minutes | 13 | 13 |
Factors associated with falling in early, treated Parkinson's disease: The NET-PD LS1 cohort.
Authors: Robert Hauser, John Fang, Sotirios Parashos, James Boyd, Zoltan Mari, Grace Liang, David Simon, Tiffini Voss, Stephen Lee, John Morgan, Lewis Sudarsky, Jorge Juncos
Journal: J Neurol Sci
Publication Date: 2017-04-11
Long-term evaluation of a phase 1 study of AADC gene therapy for Parkinson's disease.
Authors: Paul Larson, Philip Starr, Michael Aminoff
Journal: Hum Gene Ther
Publication Date: 2012-04-10
Vitamin B12 and Homocysteine Levels Predict Different Outcomes in Early Parkinson's Disease
Lead Sponsor: Annovis Bio Inc.
Collaborators: TFS Trial Form Support
Intervention / Treatment: DRUG: Placebo, DRUG: buntanetap/posiphen
Lead Sponsor: Brain Neurotherapy Bio, Inc.
Collaborators: California Institute for Regenerative Medicine (CIRM), AskBio Inc
Intervention / Treatment: BIOLOGICAL: AAV2-GDNF
Lead Sponsor: Neurocrine Biosciences
Collaborators: University of California, San Francisco, Oregon Health and Science University, Veristat, Inc., Feinstein Institute for Medical Research, Voyager Therapeutics
Intervention / Treatment: BIOLOGICAL: VY-AADC01
